Crédit Industriel et Commercial’s Checkpoint Therapeutics CKPT Stock Holding History

Crédit Industriel et Commercial’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-560,000	Closed	-$2.26M	–	383
2025 Q1	$2.26M	Buy	+560,000	New	+$1.87M	0.24%	113

Crédit Industriel et Commercial's CKPT Position: Q2 2025 in Review

Crédit Industriel et Commercial sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 560,000 shares — an estimated $2.26M sold.

Crédit Industriel et Commercial first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $2.26M in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Crédit Industriel et Commercial reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Crédit Industriel et Commercial sold 560,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $2.26M.
Crédit Industriel et Commercial first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Crédit Industriel et Commercial's Checkpoint Therapeutics position peaked at $2.26M in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Crédit Industriel et Commercial's 13F filing for Q2 2025, filed 28 Jul 2025.